Armata Pharmaceuticals (ARMP) Free Cash Flow Growth (5y) (2018 - 2026)
Armata Pharmaceuticals (ARMP) Free Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Armata Pharmaceuticals | 187.95 Mn | 183.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.25% |
| Dec 31, 2025 | -0.17% |
| Sep 30, 2025 | -2.77% |
| Jun 30, 2025 | -12.26% |
| Mar 31, 2025 | -12.11% |
| Dec 31, 2024 | -23.34% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -14.16% |
| Mar 31, 2024 | -33.02% |
| Dec 31, 2023 | -23.98% |
| Sep 30, 2023 | -43.42% |
| Jun 30, 2023 | -45.62% |
| Mar 31, 2023 | -40.82% |
| Dec 31, 2022 | -33.26% |
| Sep 30, 2022 | -79.38% |
| Jun 30, 2022 | -25.92% |
| Mar 31, 2022 | -2.57% |
| Dec 31, 2021 | -42.33% |
| Sep 30, 2021 | -11.91% |
| Jun 30, 2021 | -9.43% |